8/12/2020 6:03:24 AM
IDEAYA Biosciences Q2 Loss Per Share $0.59 Vs Loss $1.30 Last Year
8/4/2020 6:17:30 AM
IDEAYA Announces HSR Clearance Of GSK Partnership In Synthetic Lethality
7/16/2020 6:03:05 AM
IDEAYA Announces Clinical Protocol Criteria Met For Cohort Expansion In Skin Melanoma For Phase 2 GNAQ/11 Basket Trial
7/9/2020 6:01:47 AM
IDEAYA Biosciences Announces First-Patient-In In Phase 1 Combination Study Of IDE196 And Binimetinib
6/30/2020 6:01:07 AM
IDEAYA Appoints Garret Hampton To Board
6/17/2020 10:40:46 PM
IDEAYA Biosciences Prices Public Offering Of 6.67 Mln Shares At $15.00/shr
6/16/2020 4:06:30 PM
IDEAYA Announces Proposed Public Offering Of Common Stock
6/16/2020 6:01:52 AM
IDEAYA Biosciences And GlaxoSmithKline Announce Strategic Partnership In Synthetic Lethality
5/12/2020 6:02:04 AM
IDEAYA Biosciences Q1 Net Loss $12.0 Mln Vs Loss $9.6 Mln Last Year
3/24/2020 6:01:53 AM
IDEAYA Biosciences Q4 Net Loss $10.8 Mln Vs Loss $8.6 Mln Last Year
3/18/2020 6:01:27 AM
IDEAYA And Pfizer Enter Collaboration Agreement To Evaluate Clinical Combination Of IDE196 And Binimetinib